Hypersensitivity, Immediate  >>  Flutiform (fluticasone/formoterol)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Flutiform (fluticasone/formoterol) / Kyorin, Mundipharma, Vectura, Sanofi
NCT01141465: Real-world Effectiveness of Combination Therapy in Asthma

Completed
N/A
815377
Europe
Fluticasone / formoterol metered dose inhaler, Seretide MDI, Fluticasone / salmeterol dry powder inhaler, Seretide DPI, Budesonide / formoterol dry powder inhaler, Symbicort DPI, Fluticasone / salmeterol metred dose inhaler, BUD/FOR dry powder inhaler
Research in Real-Life Ltd, Mundipharma Research Limited
Asthma
06/07
02/10
NCT01739387: A Study Assessing Patient Handling of Flutiform® Breath-Actuated Inhaler (BAI) and Flutiform® Pressurised Metered Dose Inhaler (pMDI)

Completed
N/A
332
Europe
Flutiform® pMDI and Breath Actuated Inhaler (BAI)
Mundipharma Research Limited
Asthma, COPD
06/13
06/13
NCT02811315: Flutiform in Treatment of Patients With Asthma in Daily Clinical Practice.

Withdrawn
N/A
0
NA
Observational. Non interventional study
Mundipharma Pharmaceuticals B.V.
Asthma
12/16
12/16

Download Options